Clinical Study
Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days?
Table 1
Recipient and Donor Characteristics.
| Recipient Characteristics | 1.5 mg/kg x 4 days () | 2 mg/kg x 3 days () | value |
| Age, yrs | | | .136 | % of Patients >60 yrs, Number (%) | 22 (37%) | 16 (27%) | .237 | Race, Number (%) | | | .490 | White | 46 (78%) | 44 (75%) | | Black | 12 (20%) | 11 (19%) | | Gender, Number (%) | | | .456 | Female | 23 (39%) | 27 (46%) | | Weight (kg) | | | .215 | Body Mass Index (kg/m2) | | | .566 | Transplant Type, Number (%) | | | .353 | Deceased Donor | 31 (53%) | 36 (61%) | .559 | Expanded Criteria Donor | 9 (15%) | 1 (2%) | .008 | Pretransplant Dialysis | 43 (73%) | 44 (75%) | .834 | Transplant Number, Number (%) | | | | First | 57 (97%) | 58 (98%) | .559 | Cause of Renal Disease, Number (%) | | | .572 | Hypertension | 22 (37%) | 14 (24%) | | Diabetes | 10 (17%) | 10 (17%) | | Polycystic Kidney Disease | 10 (17%) | 9 (15%) | | Glomerulonephritis | 10 (13%) | 14 (24%) | | Lupus | 1 (2%) | 3 (5%) | | Other | 6 (10%) | 9 (15%) | | Donor Age | | | .412 | CMV Serostatus Donor/Recipient, Number (%) | | | .381 | Negative/negative | 8 (14%) | 10 (17%) | | Positive/negative | 16 (27%) | 9 (15%) | | Negative/positive | 17 (29%) | 16 (27%) | | Positive/positive | 18 (31%) | 24 (41%) | | Class I antibody, Number (%) | 6 (10%) | 14 (24%) | .050 | Class II antibody, Number (%) | 9 (15%) | 7 (12%) | .590 | Cold Ischemia Time, (hrs) | | | .110 | Delayed Graft Function, Number (%) | 4 (7%) | 5 (8%) | .729 |
|
|
Mean ± SD. Abbreviations: ESRD: end stage renal disease, CMV: cytomegalovirus.
|